<SEC-DOCUMENT>0001157523-18-001300.txt : 20180618
<SEC-HEADER>0001157523-18-001300.hdr.sgml : 20180618
<ACCEPTANCE-DATETIME>20180618163336
ACCESSION NUMBER:		0001157523-18-001300
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20180618
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180618
DATE AS OF CHANGE:		20180618

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			COLGATE PALMOLIVE CO
		CENTRAL INDEX KEY:			0000021665
		STANDARD INDUSTRIAL CLASSIFICATION:	PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
		IRS NUMBER:				131815595
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-00644
		FILM NUMBER:		18905034

	BUSINESS ADDRESS:	
		STREET 1:		300 PARK AVE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		2123102000

	MAIL ADDRESS:	
		STREET 1:		300 PARK AVE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a51823994.htm
<DESCRIPTION>COLGATE-PALMOLIVE COMPANY 8-K
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2018 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-family: Times New Roman; font-size: 10pt">
    <p style="text-align: center">
      <br>
      <br>
      <font style="font-family: Times New Roman; font-size: 12pt"><b>UNITED
      STATES</b></font><font style="font-size: 12pt"><br style="font-size: 12pt"></font><font style="font-family: Times New Roman; font-size: 12pt"><b>SECURITIES
      AND EXCHANGE COMMISSION</b></font><font style="font-size: 12pt"><br style="font-size: 12pt"></font><font style="font-family: Times New Roman; font-size: 12pt"><b>WASHINGTON,
      DC 20549</b></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font>
    </p>
    <hr style="width: 20%; text-align: center; height: 1.0 pt; color: #000000">


    <p style="text-align: center">

    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman; font-size: 12pt"><b>FORM 8-K</b></font><font style="font-size: 12pt"><br style="font-size: 12pt"></font><font style="font-size: 12pt"><br style="font-size: 12pt"></font><font style="font-family: Times New Roman; font-size: 12pt"><b>CURRENT
      REPORT</b></font><font style="font-size: 12pt"><br style="font-size: 12pt"></font><font style="font-family: Times New Roman; font-size: 12pt"><b>Pursuant
      to Section 13 or 15(d) of the</b></font><font style="font-size: 12pt"><br style="font-size: 12pt"></font><font style="font-family: Times New Roman; font-size: 12pt"><b>Securities
      Exchange Act of 1934</b></font><br><br><br><font style="font-family: Times New Roman; font-size: 12pt">Date
      of Report (Date of earliest event reported) June 18, 2018</font><br><br><br><font style="font-size: 12pt"><b>COLGATE-PALMOLIVE
      COMPANY</b></font><font style="font-size: 11pt"><br style="font-size: 11pt"></font><font style="font-family: Times New Roman; font-size: 12pt">(Exact
      Name of Registrant as Specified in Charter)</font><br><br>
    </p>
<div style="text-align:left">
    <table style="margin-bottom: 10.0px; font-size: 10pt; width: 100%; font-family: Times New Roman" cellspacing="0">
      <tr>
        <td style="text-align: center; padding-left: 0.0px; width: 32%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <u>Delaware</u>
          </p>
        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 2%" valign="bottom">
          &#160;
        </td>
        <td style="white-space: nowrap; text-align: center; padding-right: 0.0px; padding-left: 0.0px; width: 32%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <u>1-644</u>
          </p>
        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 2%" valign="bottom">
          &#160;
        </td>
        <td style="white-space: nowrap; text-align: center; padding-right: 0.0px; padding-left: 0.0px; width: 32%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <u>13-1815595</u>
          </p>
        </td>
      </tr>
      <tr>
        <td style="text-align: center; padding-left: 0.0px; width: 32%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            (State or Other Jurisdiction<br>of Incorporation)
          </p>
        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 2%" valign="bottom">

        </td>
        <td style="text-align: center; padding-left: 0.0px; width: 32%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            (Commission<br>File Number)
          </p>
        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 2%" valign="bottom">

        </td>
        <td style="text-align: center; padding-left: 0.0px; width: 32%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            (IRS Employer<br>Identification No.)
          </p>
        </td>
      </tr>
    </table>
    </div>
<div style="text-align:left">
    <table style="margin-bottom: 10.0px; font-size: 10pt; width: 100%; font-family: Times New Roman" cellspacing="0">
      <tr>
        <td style="text-align: center; padding-left: 0.0px; width: 50%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <u>300 Park Avenue, New York, NY</u>
          </p>
        </td>
        <td style="white-space: nowrap; text-align: center; padding-right: 0.0px; padding-left: 0.0px; width: 50%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <u>10022</u>
          </p>
        </td>
      </tr>
      <tr>
        <td style="text-align: center; padding-left: 0.0px; width: 50%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            (Address of Principal Executive Offices)
          </p>
        </td>
        <td style="text-align: center; padding-left: 0.0px; width: 50%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            (Zip Code)
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p style="text-align: center">
      Registrant&#8217;s telephone number, including area code <u>(212)&#160;310-2000</u><br>
    </p>
    <p>
      Check the appropriate box below if the Form 8-K filing is intended to
      simultaneously satisfy the filing obligation of the registrant under any
      of the following provisions (<i>see </i>General Instruction A.2. below):
    </p>
    <p style="text-indent: 30.0px; font-size: 10pt">
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Written
      communications pursuant to Rule 425 under the Securities Act (17 CFR
      230.425)</font>
    </p>
    <p style="text-indent: 30.0px; font-size: 10pt">
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Soliciting
      material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)</font>
    </p>
    <p style="text-indent: 30.0px; font-size: 10pt">
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Pre-commencement
      communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
      240.14d-2(b))</font>
    </p>
    <p style="text-indent: 30.0px; font-size: 10pt">
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Pre-commencement
      communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
      240.13e-4(c))</font>
    </p>
    <p>
      Indicate by check mark whether the registrant is an emerging growth
      company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
      &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR
      &#167;240.12b-2).<br>Emerging growth company <font style="font-size: 10pt">&#9744;</font>
    </p>
    <p style="text-align: justify">
      If an emerging growth company, indicate by check mark if the registrant
      has elected not to use the extended transition period for complying with
      any new or revised financial accounting standards provided pursuant to
      Section 13(a) of the Exchange Act. &#9744;
    </p>
    <div style="text-indent: 0pt; margin-bottom: 10pt; margin-left: 0pt; width: 100%; margin-right: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p style="white-space: nowrap">

    </p>
<div style="text-align:left">
    <table style="margin-bottom: 10.0px; font-size: 10pt; width: 100%; font-family: Times New Roman" cellspacing="0">
      <tr>
        <td style="text-align: left; padding-left: 0.0px; width: 10%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Item 5.02.</b>
          </p>
        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 90%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Departure of Directors or Certain Officers; Election of
            Directors; Appointment of Certain Officers; Compensatory
            Arrangements of Certain Officers.</b>
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p>
      On June 18, 2018, the Board of Directors of Colgate-Palmolive Company
      (the &#8220;Company&#8221;) elected Mr. Philip G. Shotts Vice President and
      Controller of the Company.&#160;&#160;In this capacity Mr. Shotts will serve as
      the Company&#8217;s principal accounting officer. Mr. Shotts, 63, joined the
      Company in 1990 and has held key financial roles at the Company, serving
      as its Vice President and Assistant Controller since 2003.
    </p>
<div style="text-align:left">
    <table style="margin-bottom: 10.0px; font-size: 10pt; width: 100%; font-family: Times New Roman" cellspacing="0">
      <tr>
        <td style="text-align: left; padding-left: 0.0px; width: 10%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Item 8.01.</b>
          </p>
        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 90%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Other Events.</b>
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p>
      On June 18, 2018, the Company issued a press release regarding the Board
      of Directors&#8217; authorization of a new share repurchase program. A copy of
      the press release is attached hereto as Exhibit 99 and is incorporated
      herein by reference.
    </p>
<div style="text-align:left">
    <table style="margin-bottom: 10.0px; font-size: 10pt; width: 100%; font-family: Times New Roman" cellspacing="0">
      <tr>
        <td style="text-align: left; padding-left: 0.0px; width: 10%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Item 9.01.</b>
          </p>
        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 90%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Financial Statements and Exhibits.</b>
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p style="white-space: nowrap">
      (d)<i>&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits</i>.&#160;&#160;The
      following exhibit is filed with this document:
    </p>
    <p style="white-space: nowrap">
      <u>Exhibit Number</u>&#160;&#160;&#160;&#160;&#160;&#160;<u>Description</u>
    </p>
    <p style="white-space: nowrap">
      99&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Press release, dated June 18, 2018,
      issued by Colgate-Palmolive Company
    </p>
    <p>

    </p>
    <div style="text-indent: 0pt; margin-bottom: 10pt; margin-left: 0pt; width: 100%; margin-right: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="font-size: 10pt; text-align: center; font-family: Times New Roman">
          2
        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
    <p style="text-align: center">
      <b>EXHIBIT INDEX</b>
    </p>
    <p>

    </p>
<div style="text-align:left">
    <table style="margin-bottom: 10.0px; font-size: 10pt; width: 100%; font-family: Times New Roman" cellspacing="0">
      <tr>
        <td style="text-align: left; padding-left: 0.0px; width: 15%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <u>Exhibit Number</u>
          </p>
        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 85%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <u>Description</u>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 15%">

        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 85%" valign="top">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="white-space: nowrap; text-align: left; padding-right: 0.0px; padding-left: 0.0px; width: 15%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <a href="a51823994ex99.htm">99</a>
          </p>
        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 85%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <a href="a51823994ex99.htm">Press release, dated June 18, 2018,
            issued by Colgate-Palmolive Company</a>
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
    <div style="text-indent: 0pt; margin-bottom: 10pt; margin-left: 0pt; width: 100%; margin-right: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="font-size: 10pt; text-align: center; font-family: Times New Roman">
          3
        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p style="text-align: left">

    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman; font-size: 10pt"><b>SIGNATURE</b></font>
    </p>
    <p style="text-indent: 30.0px; font-size: 10pt">
      <font style="font-family: Times New Roman; font-size: 10pt">Pursuant to
      the requirements of the Securities Exchange Act of 1934, the registrant
      has duly caused this report to be signed on its behalf by the
      undersigned hereunto duly authorized.</font>
    </p>
    <p>

    </p>
<div style="text-align:left">
    <table style="margin-bottom: 10.0px; font-size: 10pt; width: 100%; font-family: Times New Roman" cellspacing="0">
      <tr>
        <td style="width: 6%">

        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 48%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
        <td colspan="2" style="text-align: left; padding-left: 0.0px" valign="bottom">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>COLGATE-PALMOLIVE COMPANY</b>
          </p>
        </td>
        <td style="width: 10%">

        </td>
      </tr>
      <tr>
        <td style="width: 6%">

        </td>
        <td style="width: 48%">

        </td>
        <td style="width: 6%">

        </td>
        <td style="width: 30%">

        </td>
        <td style="width: 10%">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="width: 6%">

        </td>
        <td style="width: 48%">

        </td>
        <td style="width: 6%">

        </td>
        <td style="width: 30%">

        </td>
        <td style="width: 10%">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="padding-bottom: 2.0px; text-align: left; padding-left: 0.0px; width: 6%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Date:
          </p>
        </td>
        <td style="padding-bottom: 2.0px; text-align: left; padding-left: 0.0px; width: 48%" valign="top">
          <p style="margin-bottom: 0px; margin-top: 0px">
            June 18, 2018
          </p>
        </td>
        <td style="padding-bottom: 2.0px; text-align: left; padding-left: 0.0px; width: 6%" valign="bottom">
          By:
        </td>
        <td style="border-bottom-style: solid; text-align: left; padding-left: 0.0px; width: 30%; border-bottom-width: 1.0pt; border-bottom-color: black" valign="bottom">
          <p style="margin-bottom: 0px; margin-top: 0px">
            /s/ Jennifer M. Daniels
          </p>
        </td>
        <td style="width: 10%">

        </td>
      </tr>
      <tr>
        <td style="width: 6%">

        </td>
        <td style="width: 48%">

        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 6%" valign="bottom">
          Name:
        </td>
        <td style="text-align: left; padding-left: 20.0px; width: 30%" valign="bottom">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Jennifer M. Daniels
          </p>
        </td>
        <td style="width: 10%">

        </td>
      </tr>
      <tr>
        <td style="width: 6%">

        </td>
        <td style="width: 48%">

        </td>
        <td style="text-align: left; padding-left: 0.0px; width: 6%" valign="top">
          Title:
        </td>
        <td style="text-align: left; padding-left: 20.0px; width: 30%" valign="bottom">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Chief Legal Officer and Secretary
          </p>
        </td>
        <td style="width: 10%">

        </td>
      </tr>
    </table>
    </div>
    <p style="text-align: center">

    </p>
    <p style="text-align: center">
      4
    </p>
  </body>
</html>
<!--<!DOCTYPE html
     PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN"
     "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">-->
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>a51823994ex99.htm
<DESCRIPTION>EXHIBIT 99
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2018 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-size: 8pt; font-family: Times New Roman">
    <p style="text-align: right">
      <b>Exhibit 99</b>
    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman; font-size: 12pt"><b>Colgate
      Declares Regular Quarterly Dividend and Announces $5 Billion Share
      Repurchase Program</b></font>
    </p>
    <p>
      NEW YORK--(BUSINESS WIRE)--June 18, 2018--The Board of Directors of
      Colgate-Palmolive Company (NYSE:CL) today declared a quarterly cash
      dividend of $0.42 per common share, payable on August 15, 2018, to
      shareholders of record on July 18, 2018. The Company has paid
      uninterrupted dividends on its common stock since 1895.
    </p>
    <p>
      The Board of Directors today also authorized the repurchase of shares of
      the Company&#8217;s common stock having an aggregate purchase price of up to
      $5 billion under a new share repurchase program, which replaced the
      Company&#8217;s previous $5 billion repurchase program authorized in 2015.
      Repurchases under the new program will be made from time to time in open
      market or privately negotiated transactions at the Company&#8217;s discretion
      and in accordance with requirements of the Securities and Exchange
      Commission (SEC). The Company will commence the repurchase of shares of
      the Company&#8217;s common stock under the new program after June 18, 2018. As
      of March 31, 2018, the Company had approximately 872 million shares of
      common stock outstanding.
    </p>
    <p>
      This dividend and the new share repurchase program reflect a
      continuation of the Company&#8217;s long history of consistently returning
      cash to shareholders.
    </p>
    <p style="text-align: center">
      * * *
    </p>
    <div style="text-indent: 0pt; margin-bottom: 10pt; margin-left: 0pt; width: 100%; margin-right: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>
      About Colgate-Palmolive: Colgate-Palmolive is a leading global consumer
      products company, tightly focused on Oral Care, Personal Care, Home Care
      and Pet Nutrition. Colgate sells its products in over 200 countries and
      territories around the world under such internationally recognized brand
      names as Colgate, Palmolive, Softsoap, Irish Spring, Protex, Sorriso,
      Kolynos, elmex, Tom&#8217;s of Maine, Sanex, Ajax, Axion, Soupline, and
      Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet.
      For more information about Colgate's global business, visit the
      Company's website at <u>http://www.colgatepalmolive.com</u>. To learn
      more about Colgate&#8217;s global oral health education program, Bright
      Smiles, Bright Futures&#8482;, please visit <u>http://www.colgatebsbf.com</u>.
      CL-D
    </p>
    <p>
      <u>Cautionary Statement on Forward-Looking Statements</u>
    </p>
    <p>
      This press release contains forward-looking statements (as that term is
      defined in the&#160;U.S.&#160;Private Securities Litigation Reform Act of 1995 or
      by the SEC in its rules, regulations and releases) that set forth
      anticipated results based on management&#8217;s current plans and assumptions.
      These statements are made on the basis of the Company&#8217;s views and
      assumptions as of this time and the Company undertakes no obligation to
      update these statements whether as a result of new information, future
      events or otherwise, except as required by law or by the rules and
      regulations of the&#160;SEC. Moreover, the Company does not nor does any
      other person assume responsibility for the accuracy and completeness of
      these statements. The Company cautions investors that any such
      forward-looking statements are not guarantees of future performance and
      that actual events or results may differ materially from those
      statements. For more information about factors that could impact the
      Company&#8217;s business and cause actual results to differ materially from
      forward-looking statements, investors should refer to the Company&#8217;s
      filings with the&#160;SEC&#160;(including, but not limited to, the information set
      forth under the captions &#8220;Risk Factors&#8221; and &#8220;Cautionary Statement on
      Forward-Looking Statements&#8221; in the Company&#8217;s Annual Report on Form 10-K
      for the year ended&#160;December&#160;31, 2017&#160;and subsequent Quarterly Reports on
      Form 10-Q). Copies of these filings may be obtained upon request from
      the Company&#8217;s Investor Relations Department or on the Company's website
      at&#160;<u>http://www.colgatepalmolive.com</u>.
    </p>
    <p>

    </p>
    <p>
      CONTACT:<br>Colgate-Palmolive Company<br>John Faucher, 212-310-3653<br>or<br>Hope
      Spiller, 212-310-2291
    </p>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
